首页 | 本学科首页   官方微博 | 高级检索  
     

血管内皮生长因子结合可降解壳聚糖治疗大鼠心肌梗塞的研究
引用本文:李延民,冯艳,魏燕云,刘静,王献忠,刘俊法,周维. 血管内皮生长因子结合可降解壳聚糖治疗大鼠心肌梗塞的研究[J]. 实验动物科学, 2021, 38(4): 33
作者姓名:李延民  冯艳  魏燕云  刘静  王献忠  刘俊法  周维
摘    要:摘要:目的 研 究 血 管 内 皮 生 长 因 子 ( vascular endothelial growth factor, VEGF ) 结 合 可 降 解 壳 聚 糖 ( degradablechitosan,DC)对心肌梗塞大鼠的治疗作用。 方法 将 32 只 SD 大鼠随机分为假手术组、模型组、VEGF 组和 VEGF+ DC 组,每组 8 只。 4 组大鼠均采用结扎冠状动脉左前降支的方法进行造模,其中假手术组只穿线不结扎。 造模后, 向模型组大鼠心肌注射 100 μL 生理盐水,VEGF 组大鼠于同一位置注射同体积 VEGF 溶液,VEGF+DC 组大鼠注射 VEGF+DC 溶液。 造模 4 周 后,对 所 有 实 验 大 鼠 进 行 超 声 心 功 能 检 测,考 察 左 心 室 收 缩 期 及 舒 张 期 前 壁 厚 度( LVAW;s 和 LVAW;d) 、左心室收缩期及舒张期内径( LVID;s 和 LVID;d) 、左心室收缩期及舒张期容积( LV Vol;s 和 LV Vol;d) 、左室射血分数( EF% )及短轴缩短率( FS% ) ,血流动力学考察左室舒张末压( EDP ) 和等容收缩期及 舒张期左心室内压力上升最大速率( + dp / dt 和 - dp / dt) ,计算左心室指数( LVM / BW) 并对心肌进行苏木素-伊红 ( HE)染色观察各组实验大鼠心肌病理变化。 结果 VEGF 组和 VEGF+DC 组大鼠的心肌梗塞均得到有效改善,其 中 VEGF+DC 组的改善作用更加显著。 结论 VEGF 结合 DC 对心肌梗塞大鼠的心功能具有改善作用,具有一定的治疗作用。

关 键 词:血管内皮生长因子丨可降解壳聚糖丨心肌梗塞  

Vascular Endothelial Growth Factor Combined with Degradable Chitosan for theTreatment of Myocardial Infarction in Rats
LI Yanmin,FENG Yan,WEI Yanyun,LIU Jing,WANG Xianzhong,LIU Junfa,ZHOU Wei. Vascular Endothelial Growth Factor Combined with Degradable Chitosan for theTreatment of Myocardial Infarction in Rats[J]. Laboratory Animal Science, 2021, 38(4): 33
Authors:LI Yanmin  FENG Yan  WEI Yanyun  LIU Jing  WANG Xianzhong  LIU Junfa  ZHOU Wei
Abstract:Abstract: Objective To study the therapeutic effect of vascular endothelial growth factor ( VEGF) combined with degradable chitosan ( DC) on myocardial infarction MI rats. Method Thirty two SD rats were randomly divided into the sham operation group, the model group,the VEGF group and the VEGF +DC group, with 8 rats in each group. These rats were modeled by ligating the left anterior descending coronary artery, and the sham operation group was only threaded but not ligated. After modeling, 100 μL of normal saline was injected into the myocardium of rats in the control group, rats in VEGF group were injected with the same volume of VEGF solution at the same location, and rats in VEGF+DC group were injected with VEGF+DC solution. After 4 weeks of modeling, all ratswere subjected to echocardiographic function testing to investigate the left ventricular systolic and diastolic anterior wall thickness ( LVAW; s, LVAW; d) , left ventricular systolic and diastolic diameter ( LVID; s, LVID) ; d) , left ventricular systolic and diastolic volume ( LV Vol; s, LV Vol; d ) , left ventricular ejection fraction rate ( EF%) and short axis shortening rate ( FS%) , hemodynamic study left ventricular end diastole pressure ( EDP ) and the maximum rate of increase of left ventricular pressure during isovolumic systole and diastole ( + dp / dt, -dp / dt) , left ventricular index was calculated and the myocardium was stained with HE to observe the pathological changes of the myocardium in each group of laboratory animals. Result The myocardial infarction of rats in the VEGF group and the VEGF + DC group was effectively improved, and the improvement effect of the VEGF + DC group was more significant. The VEGF combined with DC can significantly improve various cardiac function indexes in rats with myocardial infarction. Conclusion In this study, it can be known that VEGF combined with DC can improve the cardiac function of rats with myocardial infarction and have certain therapeutic effects on myocardial infarction.
Keywords:
点击此处可从《实验动物科学》浏览原始摘要信息
点击此处可从《实验动物科学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号